Avanos Medical, Inc. Announces First Quarter 2020 Results and Provides an Update on its Response to the COVID-19 Pandemic

Go back to Avanos Medical, Inc. Announces First Quarter 2020 Results and Provides an Update on its Response to the COVID-19 Pandemic

Avanos Medical, Inc. (AVNS) Reports In-Line Q1 EPS

May 6, 2020 7:06 AM EDT

Avanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $180 million versus the consensus estimate of $175.22 million.

Full Year 2020 Outlook

Due to the rapidly evolving healthcare environment and continued... More